ZZZhijian Zhao
Zhijian Zhao
*This is an algorithmically generated author record based on publicly available information.
Zhijian Zhao has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
George D. Hartman
Department of Medicinal Chemistry, Merck Research Laboratories, Sumneytown Pike, PO Box 4, West Point, PA 19486, USA
7 shared publicationsCraig W. Lindsley
Department of Medicinal Chemistry, Merck & Co., Inc., PO Box 4, West Point, PA 19486, USA
6 shared publicationsMark E. Duggan
Department of Medicinal Chemistry, Technology Enabled Synthesis Group, Merck & Co., PO Box 4, West Point, PA 19486, USA
3 shared publicationsScott E. Wolkenberg
Department of Medicinal Chemistry, Merck & Co., Inc., PO Box 4, West Point, PA 19486, USA
3 shared publicationsAnthony V. Carella
Department of Antiviral Research, Merck & Co., Inc., PO Box 4, West Point, PA 19486, USA
2 shared publicationsCyrille Sur
Department of Neuroscience, Merck & Co., Inc., PO Box 4, West Point, PA 19486, USA
2 shared publications
Latest Publications
- 1 May 2011
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 21 (9) , 2646-2649
High concentration electrophysiology-based fragment screen: Discovery of novel acid-sensing ion channel 3 (ASIC3) inhibitors
- 1 May 2011
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 21 (9) , 2646-2649
High concentration electrophysiology-based fragment screen: Discovery of novel acid-sensing ion channel 3 (ASIC3) inhibitors
- 1 September 2010
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (17) , 5360
Corrigendum to “Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)” [Bioorg. Med. Chem. Lett. (2008) 554]
- 1 September 2010
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (17) , 5360
Corrigendum to “Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)” [Bioorg. Med. Chem. Lett. (2008) 554]
- 1 January 2008
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (2) , 554-559
Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)
- 1 January 2008
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (2) , 554-559
Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)
- 1 January 2008
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (1) , 49-53
Development of potent, allosteric dual Akt1 and Akt2 inhibitors with improved physical properties and cell activity
- 1 January 2008
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (1) , 49-53
Development of potent, allosteric dual Akt1 and Akt2 inhibitors with improved physical properties and cell activity
- 1 March 2007
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (5) , 1386-1391
Challenges in the development of mGluR5 positive allosteric modulators: The discovery of CPPHA
- 1 March 2007
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (5) , 1386-1391
Challenges in the development of mGluR5 positive allosteric modulators: The discovery of CPPHA
- 1 December 2006
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (23) , 5968-5972
Synthesis and SAR of GlyT1 inhibitors derived from a series of N-((4-(morpholine-4-carbonyl)-1-(propylsulfonyl)piperidin-4-yl)methyl)benzamides
- 1 December 2006
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (23) , 5968-5972
Synthesis and SAR of GlyT1 inhibitors derived from a series of N-((4-(morpholine-4-carbonyl)-1-(propylsulfonyl)piperidin-4-yl)methyl)benzamides
- 1 February 2005
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (4) , 905-909
Discovery of 2,3,5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitors
- 1 February 2005
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (4) , 905-909
Discovery of 2,3,5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitors